- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Olivier Goldstein
News 14 results
In the News · Source: La Lettre des Juristes d'Affaires
April 10, 2025
K&S advises the founding shareholders, managers and financiers of Apside on its acquisition agreement with CGI
Recognition
March 26, 2025
Legal 500 EMEA 2025 Ranks King & Spalding among the Top Firms in Europe, the Middle East and Africa
In the News · Source: La Lettre des Juristes d'Affaires, Global Legal Chronicle France and Le Monde du Droit
February 10, 2025
K&S advises Andera Partners on its acquisition of CDS Groupe
Recognition
August 1, 2024
The Leaders League Ranks King & Spalding Practices Among the Leaders in France
Insights 3 results
Article · Source: Option Finance
May 22, 2025
Régime des impatriés et carried interest
Article · Source: Tax Notes
February 5, 2024
Chinese Medical Device Group Prevails in French Patent Case
Article · Source: Option Finance
January 26, 2024
Dura lex sed lex... Case law reiterates the evidentiary requirements for the tax authorities in the area of transfer pricing